Home » Stocks » BELLUS Health

BELLUS Health Inc. (BLU)

Stock Price: $2.47 USD 0.05 (2.07%)
Updated Oct 22, 2020 4:00 PM EDT - Market closed
After-hours: $2.40 -0.07 (-2.83%) Oct 22, 7:25 PM

Stock Price Chart

Key Info

Market Cap 149.31M
Revenue (ttm) 16,176
Net Income (ttm) -40.33M
Shares Out 60.45M
EPS (ttm) -0.55
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 22, 2020
Last Price $2.47
Previous Close $2.42
Change ($) 0.05
Change (%) 2.07%
Day's Open 2.41
Day's Range 2.34 - 2.48
Day's Volume 954,476
52-Week Range 2.01 - 12.03

More Stats

Market Cap 149.31M
Enterprise Value 95.00M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 60.45M
Float 44.88M
EPS (basic) n/a
EPS (diluted) -0.55
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.01M
Short Ratio 0.80
Short % of Float 2.25%
Beta -0.77
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 9,229.94
PB Ratio 1.23
Revenue 16,176
Operating Income -29.59M
Net Income -40.33M
Free Cash Flow n/a
Net Cash 54.31M
Net Cash / Share 0.90
Gross Margin 100.00%
Operating Margin -182,913.64%
Profit Margin -183,304.50%
FCF Margin n/a
ROA -26.35%
ROE -45.78%
ROIC -40.40%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (8)

Buy 5
Overweight 1
Hold 2
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$6.48*
(162.35% upside)
Low
2.90
Current: $2.47
High
10.00
Target: 6.48
*Average 12-month USD price target from 6 stock analysts.

Financial Performance

Financial numbers in millions CAD.

Financial Overview

Year201920182017200820072006200520042003
Revenue0.040.040.170.721.522.823.670.33-
Revenue Growth0%-78.79%-76.92%-52.81%-46.24%-23.11%1020.8%--
Gross Profit0.040.040.170.721.522.823.670.33-
Operating Income-34.10-9.91-5.69-61.92-84.76-67.84-60.18-54.74-15.50
Net Income-34.47-9.08-1.87-59.03-81.49-66.47-59.73-52.40-16.77
Shares Outstanding55.380.460.460.460.450.360.350.280.27
Earnings Per Share-0.73-0.27-0.11-128.53-199.82-185.78-183.62-187.94-68.05
Operating Cash Flow-27.87-10.17-4.36--66.05-54.92-55.25-43.04-16.52
Capital Expenditures----0.24-0.58-0.80-1.07-14.72-0.92
Free Cash Flow-27.87-10.17-4.36--66.63-55.72-56.32-57.76-17.43
Cash & Equivalents89.9835.8623.8911.1964.1455.3178.7329.1777.59
Total Debt0.190.110.0247.2035.4233.65-10.550.84
Net Cash / Debt89.7935.7523.87-36.0128.7221.6678.7318.6276.75
Assets96.3739.2028.5026.4278.4371.4096.9576.4594.23
Liabilities7.632.112.2172.4774.5273.1246.6735.756.66
Book Value88.7437.0926.29-46.053.23-2.4449.7640.6987.57
Numbers in millions CAD, except per-share numbers.

Company Profile

Company Details

Full Name BELLUS Health Inc.
Country Canada
Employees 17
CEO Roberto Bellini

Stock Information

Ticker Symbol BLU
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: BLU

Description

BELLUS Health, a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. BELLUS Health Inc. was founded in 1993 and is headquartered in Laval, Canada.